When combined with potassium preparations or preparations digoxin, diclofenac may increase plasma concentrations of the two drugs. Various NSAID has a tendency to inhibit the activity of diuretics, and when combined with potassium-sparing diuretics may rise hyperkalemia, and must monitor serum potassium concentrations. When diclofenac potassium and other NSAID or corticosteroid drugs contracts, may increase the incidence of adverse reactions. Large doses of diclofenac potassium (200mg) can transiently inhibit platelet aggregation. In the application of methotrexate therapy with taking this product, may increase the plasma concentration of methotrexate, and its toxicity may also increase due to the impact on renal prostaglandins may increase the nephrotoxicity of cyclosporin.
Hubei Ocean Biotech Co., Ltd, a leading professional chemical industry enterprise with integrating production and trade for global valued customer with our superior quality and reliable cooperation. Should you have any interest in our APIs Pharma Products, welcome to take view at our site and be feel free to contact me.
没有评论:
发表评论